Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
34°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Haemonetics Corp
(NY:
HAE
)
84.88
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
84.88
Bid (Size)
83.62 (1)
Ask (Size)
89.00 (2)
Prev. Close
84.88
Today's Range
84.88 - 84.88
52wk Range
70.74 - 95.26
Shares Outstanding
51,029,618
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering.
April 05, 2024
For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering.
Via
Chartmill
Earnings Scheduled For February 8, 2024
February 08, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
Via
Benzinga
Performance
YTD
-0.31%
-0.31%
1 Month
+11.99%
+11.99%
3 Month
+2.76%
+2.76%
6 Month
-6.49%
-6.49%
1 Year
-0.14%
-0.14%
More News
Read More
Intuitive Surgical Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
November 17, 2023
Via
Investor's Business Daily
Intuitive Surgical Stock Rating Climbs As Sales, Profits Rise
October 16, 2023
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
October 10, 2023
Via
Benzinga
Is HAEMONETICS CORP/MASS (NYSE:HAE) suited for quality investing?
October 09, 2023
Via
Chartmill
Exploring NYSE:HAE's quality characteristics.
September 05, 2023
Via
Chartmill
Should you consider NYSE:HAE for quality investing?
August 10, 2023
Via
Chartmill
4 Analysts Have This to Say About Haemonetics
August 09, 2023
Via
Benzinga
Intuitive Surgical Stock Nearly Doubles; Gets Rating Upgrade
September 26, 2023
Via
Investor's Business Daily
Haemonetics Earnings Preview
August 07, 2023
Via
Benzinga
Haemonetics Corp. (NYSE: HAE) Making Surprising Moves in Monday Session
July 17, 2023
Via
Investor Brand Network
Haemonetics Q4 Earnings Exceed Expectations On Volume And Price Benefits
May 11, 2023
Via
Benzinga
Recap: Haemonetics Q4 Earnings
May 11, 2023
Via
Benzinga
Looking Into Haemonetics's Return On Capital Employed
February 08, 2023
Via
Benzinga
Alphabet To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Wednesday
February 08, 2023
Via
Benzinga
Earnings Preview: Haemonetics
February 06, 2023
Via
Benzinga
Where Haemonetics Stands With Analysts
January 24, 2023
Via
Benzinga
9 Analysts Have This to Say About Haemonetics
December 12, 2022
Via
Benzinga
Incyte, Haemonetics Post Earnings Beats; One Surges Within Buy Zone
February 07, 2023
Via
Investor's Business Daily
How 2022's Biggest Healthcare Gainers Could Fare In 2023
January 06, 2023
Via
MarketBeat
InMode Stock Shows Improved Technical Strength; Hits Key Technical Threshold
November 16, 2022
Via
Investor's Business Daily
Analysts Take Bullish Stance On Haemonetics, Cites Plasma Momentum As Catalyst
November 08, 2022
Via
Benzinga
Haemonetics: Q2 Earnings Insights
November 07, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
